Editorial content

Read our September 2018 edition

Our September edition includes companies and editorial features focusing on the areas of immuno-oncology, regenerative medicine and antibodies.

Go to the profile of Raveena Bhambra
Sep 10, 2018
2
0
Like 2 Comment

Read the September 2018 edition here

Go to the profile of Raveena Bhambra

Raveena Bhambra

Editor, BioPharma Dealmakers , Nature Publishing Group

Hello all, I am the Editor of BioPharma Dealmakers, a quarterly publication that assists companies in identifying potential partners in the pharmaceutical and biotechnology industry and appears in both Nature Biotechnology and Nature Reviews Drug Discovery. I am very passionate about the biopharma industry and have over 12 years of experience of working in the field, specifically in dealmaking, partnering and licensing. In my previous roles I have conducted partner searches identifying both products/technologies and partners for clients, and have edited and written dealmaking-focused reports.

No comments yet.